| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 263 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 255 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 238 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 197 | 2024 |
| Development and evaluation of sunscreen creams containing morin-encapsulated nanoparticles for enhanced UV radiation protection and antioxidant activity PK Shetty, V Venuvanka, HV Jagani, GH Chethan, VS Ligade, ... International journal of nanomedicine, 6477-6491, 2015 | 129 | 2015 |
| Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global … YH Shin, J Hwang, R Kwon, SW Lee, MS Kim, ... Allergy 78 (8), 2232-2254, 2023 | 121 | 2023 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 99 | 2024 |
| Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 95 | 2024 |
| Ban of cosmetic testing on animals: A brief overview D Sreedhar, N Manjula, A Pise, S Pise International Journal of Current Research and Review 12 (14), 113, 2020 | 58 | 2020 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 38 | 2023 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 36 | 2024 |
| Facets of technology transfer: A perspective of pharmaceutical industry MD Janodia, D Sreedhar, VS Ligade, A Pise CSIR, 2008 | 35 | 2008 |
| Fixed dose combinations: Rational or irrational? D Sreedhar, MD Janodia, VS Ligade, S Mohapatra, R Ganguly, N Udupa Current science 95 (5), 581-583, 2008 | 24 | 2008 |
| Regulatory aspects of pharmaceuticals’ exports in gulf cooperation council countries S Pateriya, MD Janodia, PB Deshpande, VS Ligade, KB Talole, ... Journal of young pharmacists 3 (2), 155-162, 2011 | 20 | 2011 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, M Abbasian, ... The lancet, 2024 | 18 | 2024 |
| Assessment of knowledge and attitude of patients on herbal medicine use in Udupi region, Karnataka, India BB Bhat, N Udupa, VS Ligade, S Khan, D Sreedhar Tropical Journal of Pharmaceutical Research 18 (1), 117-121, 2019 | 16 | 2019 |
| Impact of patents on indian pharma industry’s growth and competency: a viewpoint of pharmaceutical companies in India MD Janodia, JV Rao, S Pandey, D Sreedhar, VS Ligade, N Udupa CSIR, 2009 | 16 | 2009 |
| Digitalize pharmaceutical marketing: Medical representative perspective P Lad, P Muragundi, VS Ligade Research Journal of pharmacy and technology 10 (7), 2179-2182, 2017 | 13 | 2017 |
| Cosmeceuticals: Are they truly worth the cost? VS Ligade, D Sreedhar, J Manthan, N Udupa Indian Journal of Dermatology, Venereology and Leprology 75, 8, 2009 | 13 | 2009 |
| A survey on doctor's expectation from medical representative in Karnataka State C Ankush, SL Virendra, K Kiranshanker, D Sreedhar, J Manthan, ... International Journal of Current Research and Review 7 (8), 75, 2015 | 12 | 2015 |
